source
- Federal court blocks mailing of mifepristoneLongevity "blue zones," an update on uterine transplant science, and more Morning Rounds health newsSTAT · 2mo ago↗ source
- Windward Bio gets $165M to take China-derived drug into Phase 3 asthma trialA Swiss biotech with two experimental medicines from China, plus an in-house discovery team, has brought in $165 million to advance into late-stage testing. The startup, Windward Bio, has raised a ...Endpoints · 2mo ago↗ source
- STAT+: Biotech raises $42 million to run Huntington’s disease trialLatus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for Huntington's disease.STAT · 2mo ago↗ source